Catalog No.: PC-70022Not For Human Use, Lab Use Only.
Laniquidar (R101933) is an orally active, third-generation P-glycoprotein inhibitor that inhibits the drug efflux pump P-glycoprotein, resulting in higher concentrations of antineoplastic agents in tumor cells that are multi-drug resistant due to the overexpression of P-glycoprotein.
Laniquidar (R101933) is an orally active, third-generation P-glycoprotein (P-gp) inhibitor that inhibits the drug efflux pump P-glycoprotein, resulting in higher concentrations of antineoplastic agents in tumor cells that are multi-drug resistant due to the overexpression of P-glycoprotein.
